Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BNGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 31.61M
March 31, 2026 37.46M
December 31, 2025 44.42M
September 30, 2025 49.80M
June 30, 2025 45.37M
March 31, 2025 48.19M
December 31, 2024 35.38M
September 30, 2024 48.87M
June 30, 2024 80.34M
March 31, 2024 82.77M
December 31, 2023 96.16M
September 30, 2023 119.00M
June 30, 2023 214.76M
March 31, 2023 231.49M
December 31, 2022 249.40M
September 30, 2022 281.74M
June 30, 2022 284.73M
Date Value
March 31, 2022 311.18M
December 31, 2021 337.12M
September 30, 2021 341.56M
June 30, 2021 345.87M
March 31, 2021 362.72M
December 31, 2020 35.08M
September 30, 2020 14.68M
June 30, 2020 5.837M
March 31, 2020 -4.213M
December 31, 2019 3.614M
September 30, 2019 -7.378M
June 30, 2019 -1.345M
March 31, 2019 5.870M
December 31, 2018 10.14M
September 30, 2018 15.24M
June 30, 2018 -14.27M
March 31, 2018 -11.01M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.363B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Danaher Corp. 52.58B
Harvard Bioscience, Inc. 7.418M

Shareholders Equity (Quarterly) Related Metrics